Related Experiment Video
Updated: Jul 19, 2026

04:20
Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity
Published on: February 9, 2024
Myc overexpression enhances apoptosis induced by small molecules
Hao Mo1, Marina Vita, Marianne Crespin
1Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Cell Cycle (Georgetown, Tex.)
|October 3, 2006
Summary
Two novel small molecules, MYRAs (Myc-pathway response agents), and NSC308848, show promise in cancer treatment by targeting the Myc pathway. These compounds induce apoptosis and inhibit tumor cell transformation in Myc-overexpressing cancers.
Area of Science:
- Oncology
- Molecular Biology
- Drug Discovery
Background:
- The Myc oncogene is frequently deregulated in human cancers, making the Myc pathway a significant therapeutic target.
- Targeting the Myc pathway offers potential for developing tailored cancer treatments.
Purpose of the Study:
- To investigate the effects of novel small molecules, MYRAs (Myc-pathway response agents) and NSC308848, on Myc-driven cancers.
- To determine if these compounds can induce apoptosis and inhibit cellular transformation in a Myc-dependent manner.
Main Methods:
- Treatment of cancer cells with MYRAs and NSC308848.
- Assessment of apoptosis induction and inhibition of Myc-driven cellular transformation.
- Analysis of Myc protein levels and effects on other transcription factors.
Main Results:
- MYRAs induced apoptosis and inhibited Myc-driven transformation in a Myc-dependent manner.
- Both MYRAs and NSC308848 showed prominent effects in MYCN overexpressing neuroblastoma cells.
- NSC308848 decreased Myc protein levels and affected other transcription factors, unlike MYRAs.
Conclusions:
- MYRAs and NSC308848 represent potential therapeutic agents for Myc-related cancers.
- These compounds can elicit similar biological responses by interfering with the Myc pathway at distinct molecular levels.
- Further research into these small molecules could lead to novel cancer therapies targeting the Myc pathway.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Apoptosis
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Caspases
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.